Neuroprotection of microglial conditioned medium on 6-hydroxydopamine- induced neuronal death: Role of transforming growth factor beta-2

Journal of Neurochemistry

Volumn 110, Issue 2, 2009, Pages 545-556

  Polazzi, Elisabetta ^a   Altamira, Luis Emiliano Peña ^a   Eleuteri, Simona ^a   Barbaro, Raffaella ^a   Casadio, Chiara ^a   Contestabile, Antonio ^a   Monti, Barbara ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

6 hydroxydopamine; Cerebellar granule neurons; Conditioned medium; Microglia; Neuroprotection; Transforming growth factor 2

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; OXIDOPAMINE; RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CULTURE MEDIUM; DEGENERATIVE DISEASE; GRANULE CELL; MICROGLIA; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL DEATH; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROGLIA; MOLECULAR WEIGHT; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA2;

EID: 67649515340     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06117.x     Document Type: Article

References (75)

1. Andrews Z. B., Zhao H., Frugier T. et al. (2006) Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits. Neurobiol. Dis. 21, 568 575. (Pubitemid 43277540)
2. Bachis A., Rabin S. J., Del Fiacco M. et al. (2002) Gangliosides prevent excitotoxicity through activation of TrkB receptor. Neurotox. Res. 4, 225 234. (Pubitemid 34679373)
3. Blum D., Torch S., Lambeng N. et al. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65, 135 172. (Pubitemid 32524182)
4. Boche D., Cunningham C., Gauldie J. et al. (2003) Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J. Cereb. Blood Flow Metab. 23, 1174 1182. (Pubitemid 37229521)
5. Bové J., Prou D., Perier C. et al. (2005) Toxin-induced models of Parkinson's disease. NeuroRx. 2, 484 494. (Pubitemid 41444882)
6. Bruno V., Battaglia G., Casabona G. et al. (1998) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 18, 9594 9600. (Pubitemid 28543740)
7. Carrasco E., Werner P. Casper D. (2008) Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress. Neurosci. Lett. 15, 44 49.
8. Chen G., Bower K. A., Ma C. et al. (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. 18, 1162 1164. (Pubitemid 39561557)
9. Constam D. B., Philipp J., Malipiero U. V. et al. (1992) Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J. Immunol. 148, 1404 1410.
10. Constam D. B., Schmid P., Aguzzi A. et al. (1994) Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation. Eur. J. Neurosci. 6, 766 778.
11. Contestabile A. (2002) Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 1, 41 55. (Pubitemid 44133846)
12. D'Mello S. R., Galli C., Ciotti T. et al. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl Acad. Sci. USA 90, 10989 10993.
13. De Groot C. J., Montagne L., Barten A. D. et al. (1999) Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J. Neuropathol. Exp. Neurol. 58, 174 187. (Pubitemid 29088941)
14. Dodel R. C., Du Y., Bales K. R. et al. (1999) Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res. Mol. Brain Res. 64, 141 148. (Pubitemid 29049246)
15. Eleuteri S., Polazzi E. Contestabile A. (2008) Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells. Neurosci. Lett. 448, 74 78.
16. Elvers M., Pfeiffer J., Kaltschmidt C. et al. (2005) TGF-beta2 neutralization inhibits proliferation and activates apoptosis of cerebellar granule cell precurors in the developing cerebellum. Mech. Dev. 122, 587 602. (Pubitemid 40445359)
17. Figueiredo C., Pais T. F., Gomes J. R. Chatterjee S. (2008) Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2. J. Neurochem. 107, 73 85.
18. Flanders K. C., Ren R. F. Lippa C. F. (1998) Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71 85. (Pubitemid 28049820)
19. Fukushima T., Liu R. Y. Byrne J. H. (2007) Transforming growth factor-beta2 modulates synaptic efficacy and plasticity and induces phosphorylation of CREB in hippocampal neurons. Hippocampus 17, 5 9. (Pubitemid 46218669)
20. Gallo V., Kingsbury A., Balazs R. et al. (1987) The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J. Neurosci. 7, 2203 2213. (Pubitemid 17114929)
21. Garden G. A. Möller T. (2006) Microglia biology in health and disease. J. Neuroimmune Pharmacol. 1, 127 137. (Pubitemid 44257488)
22. González-Scarano F. Baltuch G. (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219 240. (Pubitemid 29144887)
23. Goris A., Williams-Gray C. H., Foltynie T. et al. (2007) Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson's disease. J. Neurol. 25, 846 848. (Pubitemid 47222297)
24. Grygielko E. T., Martin W. M., Tweed C. et al. (2005) Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J. Pharmacol. Exp. Ther. 313, 943 951. (Pubitemid 40726998)
25. Hanisch U. K. Kettenmann H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387 1394. (Pubitemid 350014685)
26. Hansen M. B., Nielsen S. E. Berg K. (1998) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203 210. (Pubitemid 19132276)
27. Hicks D., Heidinger V., Mohand-Said S. et al. (1989) Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen. Pharmacol. 30, 265 273.
28. Horvath R. J., Nutile-McMenemy N., Alkaitis M. S. et al. (2008) Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J. Neurochem. 107, 557 569.
29. Inman G. J., Nicolás F. J., Callahan J. F. et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65 74. (Pubitemid 34680517)
30. Kaltschmidt B. Kaltschmidt C. (2001) DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons. Mech. Dev. 101, 11 19. (Pubitemid 32186307)
31. Kane C. J., Brown G. J. Phelan K. D. (1996) Transforming growth factor-beta 2 both stimulates and inhibits neurogenesis of rat cerebellar granule cells in culture. Dev. Brain Res. 96, 46 51. (Pubitemid 26348281)
32. Klegeris A., McGeer E. G. McGeer P. L. (2007) Therapeutic approaches to inflammation in neurodegenerative disease. Curr. Opin. Neurol. 20, 351 357. (Pubitemid 46743120)
33. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312 318. (Pubitemid 26349059)
34. Krieglstein K., Strelau J., Schober A. et al. (2002) TGF-beta and the regulation of neuron survival and death. J. Physiol. Paris 96, 25 30. (Pubitemid 34087030)
35. Lai A. Y. Todd K. G. (2008) Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 56, 259 270.
36. Laping N. J., Grygielko E., Mathur A. et al. (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58 64. (Pubitemid 34680516)
37. Levi G., Patrizio M., Bernardo A. et al. (1993) Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc. Natl Acad. Sci. USA 90, 1541 1545.
38. Lin S., Wei X., Xu Y. et al. (2003) Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons. Life Sci. 72, 1635 1641. (Pubitemid 36120789)
39. Lindholm D., Dechant G., Heisenberg C. P. et al. (1993) Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5, 1455 1464. (Pubitemid 23325228)
40. de Luca A., Weller M. Fontana A. (1996) TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J. Neurosci. 16, 4174 4185.
41. Ma N. Streilein J. W. (1999) T cell immunity induced by allogeneic microglia in relation to neuronal retina transplantation. J. Immunol. 162, 4482 4489. (Pubitemid 29314845)
42. Ma Z., Wei X., Fontanilla C. et al. (2006) Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. Life Sci. 79, 1307 1311. (Pubitemid 44188796)
43. Macauley S. L., Horsch A. D., Oterdoom M. et al. (2004) The effect of transforming growth factor-beta2 on dopaminergic graft survival. Cell Transplant. 13, 245 252. (Pubitemid 38620965)
44. McGeer P. L. McGeer E. G. (2008) Glial reactions in Parkinson's disease. Mov. Disord. 23, 474 483.
45. Monti B., Zanghellini P. Contestabile A. (2001) Characterization of ceramide-induced apoptotic death in cerebellar granule cells in culture. Neurochem. Int. 39, 11 18. (Pubitemid 32304450)
46. Monti B., Polazzi E., Batti L. et al. (2007) Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. J. Neurochem. 103, 518 530. (Pubitemid 47498025)
47. Morgan T. E., Nichols N. R., Pasinetti G. M. Finch C. E. (1993) TGF-beta 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120, 291 301. (Pubitemid 23165023)
48. Nakajima K., Honda S., Tohyama Y. et al. (2001) Neurotrophin secretion from cultured microglia. J. Neurosci. Res. 65, 322 331. (Pubitemid 32727034)
49. Neumann H. (2001) Control of glial immune function by neurons. Glia 36, 191 199. (Pubitemid 33055907)
50. Olanow C. W. (2007) The pathogenesis of cell death in Parkinson's disease. Mov. Disord. 22, S335 S342.
51. Park L. C., Zhang H. Gibson G. E. (2001) Co-culture with astrocytes or microglia protects metabolically impaired neurons. Mech. Ageing Dev. 123, 21 27. (Pubitemid 32972255)
52. Polazzi E. Contestabile A. (2002) Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev. Neurosci. 13, 221 242. (Pubitemid 35178154)
53. Polazzi E. Contestabile A. (2006) Overactivation of LPS-stimulated microglial cells by co-cultured neurons or neuron-conditioned medium. J. Neuroimmunol. 172, 104 111. (Pubitemid 43277495)
54. Polazzi E., Gianni T. Contestabile A. (2001) Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling. Glia 36, 271 280. (Pubitemid 34010056)
55. Raivich G. (2005) Like cops on the beat: the active role of resting microglia. Trends Neurosci. 28, 571 573. (Pubitemid 41476686)
56. Roussa E., Wiehle M., Dünker N. et al. (2006) Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon. Stem Cells 24, 2120 2129. (Pubitemid 44477137)
57. Samanta A., Li B., Song X. et al. (2008) TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl Acad. Sci. USA 105, 14023 14027.
58. Schmierer B. Hill C. S. (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8, 970 982. (Pubitemid 350174642)
59. Schwartz M., Butovsky O., Bruck W. et al. (2006) Microglial phenotype: is the commitment reversible? Trends Neurosci. 29, 68 74. (Pubitemid 43202595)
60. Siglienti I., Chan A., Kleinschnitz C. et al. (2007) Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. J. Neuropathol. Exp. Neurol. 66, 47 56. (Pubitemid 46066788)
61. Smith P. F. (2008) Inflammation in Parkinson's disease: an update. Curr. Opin. Investig. Drugs 9, 478 484. (Pubitemid 351677901)
62. Streit W. J. (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133 139. (Pubitemid 35337371)
63. Streit W. J. (2006) Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci. 29, 506 510. (Pubitemid 44291814)
64. Streit W. J., Walter S. A. Pennel N. A. (1999) Reactive microgliosis. Prog. Neurobiol. 57, 563 581. (Pubitemid 29148415)
65. Streit W. J., Miller K. R., Lopes K. O. et al. (2008) Microglial degeneration in the aging brain-bad news for neurons? Front. Biosci. 13, 3423 3438. (Pubitemid 351594693)
66. Toku K., Tanaka J., Yano H. et al. (1998) Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J. Neurosci. Res. 53, 415 425. (Pubitemid 28363203)
67. Villoslada P., Moreno B., Melero I. et al. (2008) Immunotherapy for neurological diseases. Clin. Immunol. 128, 294 305.
68. Vollmar P., Haghikia A., Dermietzel R. et al. (2008) Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int. J. Neuropsychopharmacol. 11, 111 117.
69. Whitton P. S. (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963 976. (Pubitemid 46628616)
70. Wright A. K., Miller C., Williams M. et al. (2008) Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression. Brain Res. 24, 78 86.
71. Yuan L. Neufeld A. H. (2001) Activated microglia in the human glaucomatous optic nerve head. J. Neurosci. Res. 64, 523 532. (Pubitemid 32521772)
72. Zhang H. L., Gu Z. L., Savitz S. I. et al. (2008) Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation. J. Neurosci. Res. 86, 1132 1141.
73. Zhu Y., Yang G. Y., Ahlemeyer B. et al. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898 3909. (Pubitemid 37465698)
74. Zhu Y., Culmsee C., Klumpp S. et al. (2004) Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience 123, 897 906. (Pubitemid 38130100)
75. Zietlow R., Dunnett S. B. Fawcett J. W. (1999) The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur. J. Neurosci. 11, 1657 1667. (Pubitemid 29192241)